BIOLASE Announces Pricing of $8.5 Million Public Offering of Common Stock and Concurrent Private Placement of Convertible Preferred Stock Oct 24, 2019 9:35pm EDT
BIOLASE Announces Select Preliminary Third Quarter 2019 Financial Results And Date For Reporting Third Quarter 2019 Results Oct 21, 2019 7:00am EDT
BIOLASE Announces First-Ever U.S. & Canada Regulatory Clearance of Laser Crown and Veneer Removal Oct 15, 2019 9:00am EDT
BIOLASE to Participate at Dougherty & Company Institutional Investor Conference on September 5, 2019 Aug 28, 2019 7:30am EDT
